Patents Represented by Attorney, Agent or Law Firm Bozicevic, Field and Francis LLP
  • Patent number: 8337583
    Abstract: Soil amendment/foliar nutrient compositions and methods for their manufacture and use are provided. The compositions are aqueous compositions that include a carbon skeleton energy component (CSE); a macronutrient; a vitamin cofactor; a complexing agent; and at least one of exotic micronutrient component and an ionophore component.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: December 25, 2012
    Inventor: Thomas T. Yamashita
  • Patent number: 8334297
    Abstract: 2,4-Pyrimidinediamine compounds represented by formula (I), methods for preparing the same and methods for treating an inflammatory disorder and for inhibiting the production of IL-23 and/or stimulating the production of IL-10 using the same:
    Type: Grant
    Filed: January 13, 2010
    Date of Patent: December 18, 2012
    Assignee: Rigel Pharmaceuticals Inc.
    Inventors: Hui Li, Esteban Masuda, Stephanie Yung, Taisei Kinoshita, Rongxian Ding, Rajinder Singh, Tarikere Gururaja, Donald G. Payan, Kin Tso
  • Patent number: 8334238
    Abstract: The invention relates to novel methods of detecting alterations in cell cycle regulation in a cell or a cell population and screening for agents capable of modulating cell cycle regulation through the use of multiparameter assays and a fluorescence-activated cell sorter (FACS) machine.
    Type: Grant
    Filed: April 16, 1999
    Date of Patent: December 18, 2012
    Assignee: Rigel, Inc.
    Inventors: Joseph Fisher, James Lorens, Donald Payan, Alexander Rossi
  • Patent number: 8332737
    Abstract: Methods, systems and computer readable media for controlling an instrument in communication with a host computer are provided. Operations of an instrument that must be completed on schedule are controlled via an embedded controller embedded in the instrument. A complete status packet is sent to a host computer from the embedded controller. Periodically, the embedded controller repeats the sending of a complete status packet to the host computer, wherein status values in the complete status packet are updated with each iteration of sending a complete status packet.
    Type: Grant
    Filed: June 26, 2009
    Date of Patent: December 11, 2012
    Assignee: Agilent Technologies, Inc.
    Inventors: Peter G. Webb, Jayati Ghosh, Bo Curry
  • Patent number: 8329212
    Abstract: The potential for substance abuse involving residual amounts of abusable substances remaining in used skin-worn patches is reduced by the provision of a system and method for combining the abusable substance with a separate anti-abuse substance agent as part of a removal or disposal procedure.
    Type: Grant
    Filed: November 19, 2009
    Date of Patent: December 11, 2012
    Assignee: Teikoku Pharma USA, Inc.
    Inventors: Carter R. Anderson, Russell L. Morris
  • Patent number: 8329432
    Abstract: Certain embodiments provide a method for crystallizing a GPCR. The method may employ a fusion protein comprising: a) a first portion of a G-protein coupled receptor (GPCR), where the first portion comprises the TM1, TM2, TM3, TM4 and TM5 regions of the GPCR; b) a stable, folded protein insertion; and c) a second portion of the GPCR, where the second portion comprises the TM6 and TM7 regions of the GPCR.
    Type: Grant
    Filed: February 16, 2011
    Date of Patent: December 11, 2012
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Brian Kobilka, Daniel Rosenbaum
  • Patent number: 8329398
    Abstract: The invention relates to methods of using fragmented RNA, such as RNA obtained from archived fixed paraffin-embedded tissue material (FPET RNA) or other clinically biopsied tissue specimens for universal gene expression profiling.
    Type: Grant
    Filed: December 18, 2007
    Date of Patent: December 11, 2012
    Assignee: Genomic Health, Inc.
    Inventors: Michael C. Kiefer, Kenneth W. Hoyt
  • Patent number: 8324815
    Abstract: LED lighting systems and methods of manufacture, which include one or more of the following: (1) a solid state active heat sink for cooling one or more LED chips; (2) a front end power supply providing high voltage to the active heat sink component; (3) a front end power supply that provides a relatively low voltage load to a plurality of LED chips; (4) a front end hybrid power supply with both a high and low voltage output, wherein the high voltage is at least 2 kV higher than the low voltage output; (5) an over-mold encapsulating the front end components, wherein the over-mold is provided by a reaction injection molding process; (6) a digital micro-minor device (DMD) for providing pixilated light, color mixing, and intensity control; and (7) an optic having quantum dots (QDs), wherein the light output of the DMD activates for the QDs.
    Type: Grant
    Filed: January 24, 2011
    Date of Patent: December 4, 2012
    Assignee: Biological Illumination, LLC
    Inventors: Fredric S. Maxik, David E. Bartine, Robert R. Soler, Valerie Ann Bastien, James Lynn Schellack, Eliza Katar Grove
  • Patent number: 8324808
    Abstract: A light-emitting diode (LED) lamp for producing a biologically-corrected light. In one embodiment, the LED lamp includes a color filter, which modifies the light produced by the lamp's LED chips, to increase spectral opponency and minimize melatonin suppression. In doing so, the lamp minimizes the biological effects that the lamp may have on a user. The LED lamp is appropriately designed to produce such biologically-correct light, while still maintaining a commercially acceptable color temperature and commercially acceptable color rending properties. Methods of manufacturing such a lamp are provided, as well as equivalent lamps and equivalent methods of manufacture.
    Type: Grant
    Filed: June 30, 2011
    Date of Patent: December 4, 2012
    Assignee: Biological Illumination, LLC
    Inventors: Fredric S. Maxik, Robert R. Soler, David E. Bartine
  • Patent number: 8326388
    Abstract: A method and apparatus for non-invasive measurement of living body information comprises a light source configured to generate light containing a specific wavelength component, an irradiation unit configured to irradiate a subject with the light, and at least one acoustic signal detection unit including piezoelectric devices formed of a piezoelectric single crystal containing lead titanate and configured to detect an acoustic signal which is generated due to the energy of the irradiation light absorbed by a specific substance present in or on a subject.
    Type: Grant
    Filed: October 28, 2003
    Date of Patent: December 4, 2012
    Assignee: Toshiba Medical Systems Corporation
    Inventors: Shoichi Kanayama, Kazuhiro Itsumi, Omar S. Khalil, Stanislaw Kantor
  • Patent number: 8324149
    Abstract: Methods are provided for the utilization of bacterial cell-free extracts in the synthesis of high yields of virus like particles with encapsidated cargo.
    Type: Grant
    Filed: November 18, 2009
    Date of Patent: December 4, 2012
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Bradley C. Bundy, James R. Swartz, Wei Chan
  • Patent number: 8324785
    Abstract: Piezoelectric actuators are provided. In some instances, the piezoelectric actuators are high-precision piezoelectric actuators. The piezoelectric beams may have a bi-chevron configuration. Also provided are methods of making the piezoelectric actuators, e.g., using Micro-Electro-Mechanical System (MEMS) fabrication techniques, and methods of using the piezoelectric actuators, e.g., as valves in fluid dispensing systems.
    Type: Grant
    Filed: November 10, 2009
    Date of Patent: December 4, 2012
    Assignee: The Regents of the University of California
    Inventors: Ya-Mei Chen, Michael Stephen Sheppy, Matthew A. Hopcroft, Albert P. Pisano, Rajesh Vinodrai Mehta, Michael Alan Marcus, Gilbert Allan Hawkins
  • Patent number: 8323975
    Abstract: Telomere-encoding nucleic acid nanocircles, methods for their preparation, and methods for their use are disclosed. The nanocircles can be constructed containing multiple repeats of the complement of telomere repeat sequences. The telomere-encoding nanocircles are useful for extending telomeres both in vitro and in vivo, for treating macular degeneration, the effects of skin aging, liver degeneration, and cancer. The nanocircles are further useful for treating cell cultures to produce long-lived non-cancerous cell populations. This use has wide applicability in scientific research, tissue engineering, and transplantation.
    Type: Grant
    Filed: January 26, 2009
    Date of Patent: December 4, 2012
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventor: Eric T. Kool
  • Patent number: 8318678
    Abstract: The present invention generally features novel cosmetic skin and hair care compositions for enhancing the appearance of eyelashes and eyebrows. Specifically, the topical skin and hair care compositions of the invention contain a concentration of at least one of pentapeptide-17 tetrapeptide-12 that provide for thicker, longer and more voluminous appearing eyelashes and eyebrows. The cosmetic formulations of the invention may further include cosmetically acceptable vehicle(s) and/or other skin and hair conditioning agents.
    Type: Grant
    Filed: May 30, 2008
    Date of Patent: November 27, 2012
    Assignee: Jan Marini Skin Research
    Inventor: Jan L. Marini
  • Patent number: 8318185
    Abstract: The present invention refers to a recombinant malaria vaccine and a method for its manufacture.
    Type: Grant
    Filed: January 11, 2008
    Date of Patent: November 27, 2012
    Assignee: Ruprecht-Karls-Universität Heidelberg
    Inventors: Hermann Bujard, Rolf Lutz, Christian Kauth, Christian Epp, Ute Wöhlbier
  • Patent number: 8318093
    Abstract: Magnetic nanoparticles and methods for their use in detecting biological molecules are disclosed. The magnetic nanoparticles can be attached to nucleic acid molecules, which are then captured by a complementary sequence attached to a detector, such as a spin valve detector or a magnetic tunnel junction detector. The detection of the bound magnetic nanoparticle can be achieved with high specificity and sensitivity.
    Type: Grant
    Filed: May 17, 2007
    Date of Patent: November 27, 2012
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Shan X. Wang, Robert L. White, Chris D. Webb, Guanxiong Li
  • Patent number: 8318433
    Abstract: The invention provides methods and compositions for attaching oligonucleotide tags to polynucleotides for the purpose of carrying out analytical assays in parallel and for decoding the oligonucleotide tags of polynucleotides selected in such assays. Words, or subunits, of oligonucleotide tags index submixtures in successively more complex sets of submixtures (referred to herein as “tiers” of submixtures) that a polynucleotide goes through while successive words are added to a growing tag. By identifying each word of an oligonucleotide tag, a series of submixtures is identified including the first submixture that contains only a single polynucleotide, thereby providing the identity of the selected polynucleotide. The analysis of the words of an oligonucleotide tag can be carried out in parallel, e.g. by hybridization of the oligonucleotide tag to its tag complement on an addressable array; or such analysis can be carried out serially by successive hybridizations of labeled word complements.
    Type: Grant
    Filed: March 20, 2012
    Date of Patent: November 27, 2012
    Assignee: Population Genetics Technologies Ltd.
    Inventor: Sydney Brenner
  • Patent number: 8313013
    Abstract: The invention includes an assembly for anastomosis having a clamp being arranged to support a fastener. The clamp can be actuated to join a vessel with the fastener to establish a fluid communication. In some embodiments, the invention includes an assembly having a clamp and a fastener with first and second joinable parts, and the assembly can be adapted to facilitate the alignment of the first and second joinable parts.
    Type: Grant
    Filed: April 6, 2006
    Date of Patent: November 20, 2012
    Assignee: Synovis Life Technologies, Inc.
    Inventors: William F. Kuester, III, Tracy Konobeck
  • Patent number: 8309102
    Abstract: The present invention relates, in part, to methods and compositions for immunizing against infection by Chlamydia trachomatis. The methods and compositions rely, in part, on administering an immunogenic composition comprising one or more peptides derived from C. trachomatis major outer membrane protein (MOMP) to a subject to be immunized. In some embodiments, the compositions comprise a chimeric immunogens, expression vectors comprising the polynucleotides, and kits comprising the compositions are also provided.
    Type: Grant
    Filed: May 11, 2011
    Date of Patent: November 13, 2012
    Assignee: Children's Hospital and Research Center at Oakland
    Inventors: Randall J. Mrsny, Deborah Dean
  • Patent number: 8309320
    Abstract: The invention features methods and compositions for diagnosis, including prognosis, of conditions associated with decreased arginine bioavailability (which can result from dysregulated arginine metabolism, e.g., due to increased arginase activity) by assessing in a sample from a subject the ratio of arginine to one or more, usually two or more, modulators of arginine bioavailability. In one embodiment, the ratio of arginine to (ornithine+citrulline) is assessed to aid in diagnosis.
    Type: Grant
    Filed: December 1, 2009
    Date of Patent: November 13, 2012
    Assignees: Children's Hospital & Research Center at Oakland, The Cleveland Clinic Foundation
    Inventors: Claudia R. Morris, Stanley L. Hazen